Stay updated on Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPage now includes a government-operating-status notice and a new revision tag (v3.2.0), replacing the old revision (v3.0.2).SummaryDifference1%
- Check21 days agoChange DetectedUpdated page now includes a current date and a new Study Status Contacts/Locations section, while an older date (2025-09-10) was removed.SummaryDifference0.1%
- Check28 days agoChange Detected- Updated revision label from v3.0.1 to v3.0.2. - Removal of a Back to Top element. Overall, this is a minor, non-substantive update focused on versioning and navigation rather than core content or functionality.SummaryDifference0.1%
- Check35 days agoChange DetectedMajor data-model upgrade: adds facility/location data and a large set of Study Status/Contacts-Locations entries, removes legacy location fields, and bumps revision to v3.0.1.SummaryDifference100%
- Check61 days agoChange DetectedThe web page has been updated to a new version, v2.16.12, with the previous version, v2.16.11, being removed. Additionally, a date of 2025-08-11 has been added.SummaryDifference0.7%
- Check68 days agoChange DetectedThe web page has been updated to reflect a new version, v2.16.11, replacing the previous version v2.16.10. Additionally, a date has been added, indicating a future update on August 5, 2025.SummaryDifference1.0%
Stay in the know with updates to Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.